AUPH icon

Aurinia Pharmaceuticals
AUPH

Overview Fund Activity

78 hedge funds and large institutions have $194M invested in Aurinia Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 5 closing their positions.

Holders
78
Holders Change
+17
Holders Change %
+27.87%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
18
Reduced
19
Closed
5
Calls
$3.92M
Puts
$3.46M
Net Calls
+$462K
Net Calls Change
+$1.93M

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$27.4M
2
O
2
OrbiMed
New York
$20.5M
3
NMC
3
NEA Management Company
Maryland
$33.6M
4
RG
4
Redmile Group
California
$2.1M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$3.7M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$29.6M
2
A
2
Abingworth
United Kingdom
$0
3
Goldman Sachs
3
Goldman Sachs
New York
$8.97M
4
Franklin Resources
4
Franklin Resources
California
$10.5M
5
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$118K
Name Holding Trade Value Shares
Change 		Shares
Change %
Daiwa Securities Group
76
Daiwa Securities Group
Japan
$3K – – –
ASN
77
Advisory Services Network
Georgia
$3K +$3K +500 New
A
78
Abingworth
United Kingdom
– -$2.72M -400,434 Closed
Man Group
79
Man Group
United Kingdom
– -$143K -20,900 Closed
VF
80
Virtu Financial
New York
– -$105K -15,458 Closed
LCS
81
Levin Capital Strategies
New York
– -$68K -10,000 Closed
Simplex Trading
82
Simplex Trading
Illinois
– -$20K -2,944 Closed
1 2 3
4